Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐ EuReg )

Helicobacter · Published 2026-01-01 · DOI 10.1111/hel.70107

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1111/hel.70107

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg ) · Helicobacter · 2025 · Same journal
• A Three‐Way Comparison of Nodular Lesions in H. pylori ‐Induced Gastritis, Non‐ Helicobacter pylori Helicobacter ( NHPH )‐Induced Gastritis, and NHPH ‐Induced MALT Lymphoma Reveals Their Distinct Endoscopic Predictors: Distribution for Bacterial Etiology and Morphology for Malignancy · Helicobacter · 2025 · Same journal
• Helicobacter pylori and Impaired Early Childhood Development—Evidence From a Birth Cohort Study From Ghana and Côte d'Ivoire · Helicobacter · 2025 · Same journal
• Advancing Gastric Cancer Prevention in Korea: Current Strategies and Future Directions · Helicobacter · 2026 · Same journal
• High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy · Helicobacter · 2026 · Same journal
• Different Doses of Ilaprazole for Dual Therapy Versus Bismuth‐Quadruple Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial · Helicobacter · 2025 · Same journal
• Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial · Helicobacter · 2026 · Same journal
• Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America · Helicobacter · 2026 · Same journal
• Current Status of Diagnosis, Treatment, and Prevention of Helicobacter pylori Infection in China: A 2024–2025 National Multicenter Cross‐Sectional Study · Helicobacter · 2026 · Same journal
• Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp‐ EuReg ) · Helicobacter · 2026 · Same journal